- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02463955
Exploration of the Pleural Cavity Using a fleXible endoscoPe (EXPLORE)
August 16, 2016 updated by: University Hospital, Rouen
Exploration of the Pleural Cavity Using a fleXible endoscoPe Under Two-Lung ventilatiOn With contRollEd Capnothorax
EXPLORE is a first-in-human study of single port transdiaphragmatic thoracoscopy using a flexible gastro-intestinal endoscope under two-lung ventilation with controlled capnothorax.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Thoracoscopy is usually performed either with rigid thoracoscopes, or with flexible bronchoscopes.
The latter is less invasive and less expensive, but flexible bronchoscopes are difficult to manipulate within the pleural cavity and do not provide an adequate orientation within the pleural space.
It is therefore associated with a lower diagnostic yield than thoracoscopy with rigid thoracoscopes.
On the other hand, rigid thoracoscopes are associated with more pain, a higher cost, and usually require one-lung ventilation.
Gastro-intestinal endoscopes allow a better orientation than bronchoscopes in cavities, and have wider operative channels.
The EXPLORE study investigates the feasibility and safety of single port transdiaphragmatic thoracoscopy using a flexible gastro-intestinal endoscope under two-lung ventilation with controlled capnothorax.
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of pleural effusion affirmed by chest radiography,
- Indication thoracoscopy, asked by the pulmonologist or thoracic surgeon for diagnostic investigation and / or pleural symphysis
- Inpatient or outpatient,
- Women of childbearing age having an effective contraceptive coverage (combined oral contraceptives or intrauterine device or tubal ligation); a negative pregnancy test should be obtained,
- For postmenopausal women, menopause confirmation of diagnosis,
Exclusion Criteria:
- Pleural effusion compression,
- Pleural effusion infected or suspected of infection,
- Febrile patient (> 38 ° C)
- Parapneumonic effusion
- Immunosuppression (eg, neutropenia <1G / L, immunosuppressive therapy, ...)
- Portage known multidrug-resistant germ or S. aureus resistant to methicillin,
- Clinical suspicion of tuberculosis,
- Patients who have already been treated by pleurodesis,
- Contraindication to general anesthesia,
- Contraindication of prophylactic antibiotics,
- Contraindication to pleurodesis agent
- Increased bleeding risk,
- No one deprived of liberty by an administrative or judicial decision or protected adult subject (under guardianship)
- Pregnant or breastfeeding women.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Thoracoscopy
|
Thoracoscopy is done using flexible video endoscope
Thoracoscopy is done using video-rigid thoracoscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Completeness of the pleural cavity exploration using the flexible endoscope
Time Frame: at 0 hours
|
Two independent experts will visualize the video-recordings of the intervention and evaluate the completeness of the exploration using a standardized score.
|
at 0 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outcome of a complication
Time Frame: at 0 hours
|
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
|
at 0 hours
|
Outcome of a complication
Time Frame: at 4 hours
|
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
|
at 4 hours
|
Outcome of a complication
Time Frame: Day 7
|
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
|
Day 7
|
Outcome of a complication
Time Frame: 1 month
|
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
|
1 month
|
Results of the microbiological analysis of samples collected on the endoscope seven days before the intervention
Time Frame: Day -7 : 7 days before the intervention
|
Day -7 : 7 days before the intervention
|
|
Results of the microbiological analysis of samples collected on the endoscope the day of the intervention
Time Frame: at 0 hours
|
at 0 hours
|
|
Completeness of the pleural cavity exploration using the standard three-ports thoracoscopy with one-lung ventilation
Time Frame: at 0 hours
|
Two independent experts will visualize the video-recordings of the intervention and evaluate tee completeness of the exploration using a standardized score.
|
at 0 hours
|
Diagnostic yield of biopsies performed with the flexible endoscope
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: BASTE Jean Marc, MD, Rouen University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
April 30, 2015
First Submitted That Met QC Criteria
June 3, 2015
First Posted (Estimate)
June 4, 2015
Study Record Updates
Last Update Posted (Estimate)
August 17, 2016
Last Update Submitted That Met QC Criteria
August 16, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/182/HP
- 2014-A01660-47 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusion
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Oregon Health and Science UniversityThe Gerber FoundationCompletedChylous Pleural Effusion Following Cardiothoracic SurgeryUnited States
-
Sheng HuWuhan Binhui Biotechnology Co., Ltd.RecruitingMalignant Pleural Effusion | Malignant Peritoneal EffusionChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPleural NeoplasmUnited States
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
JemincareZhejiang Hangyu Pharmaceutical Co., LtdRecruitingMalignant Pleural EffusionChina
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruiting
-
Washington University School of MedicineMerit Medical Systems, Inc.CompletedMalignant Pleural EffusionUnited States
-
Duke UniversityTerminated
Clinical Trials on flexible video endoscope
-
National Cancer Institute, EgyptCompleted
-
University of ArkansasTerminatedDiagnostic or Therapeutic LaparoscopyUnited States
-
3NT Medical Ltd.Completed
-
St. Luke's-Roosevelt Hospital CenterEthicon Endo-SurgeryWithdrawnPain | CholelithiasisUnited States
-
3NT Medical Ltd.Completed
-
Chinese University of Hong KongUnknownNasopharyngeal Carcinoma
-
University Hospital Inselspital, BerneRecruiting
-
Vanderbilt University Medical CenterNational Institutes of Health (NIH); National Institute for Biomedical Imaging...CompletedColonoscopyUnited States
-
Biosignatures LimitedNewcastle-upon-Tyne Hospitals NHS TrustCompletedUrinary Bladder Neoplasms
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted